產(chǎn)品詳情
簡單介紹：
Anti-HPV31 E7抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-HPV31 E7抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-HPV31 E7
Cat. Number:
Anti-HPV31 E7抗體KL-10203R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient forAnti-HPV31 E7抗體 HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. Human papillomaviruses (HPV) are small DNA viruses which infect epithelia of the skin and mucosa. Over 90 types have been identified and they mostly cause a variety of benign lesions such as warts and verrucae. However, some subtypes, notably types 16 and 18, 31 and 33, have been confirmed as agents which cause cervical cancer.
Also known as:
VE7_HPV31; Protein E7; E7; Human Anti-HPV31 E7抗體Papilloma Virus; Human papillomavirus type 31 E7; Human papillomavirus type 31 (E7); Human papillomavirus type 31 E7; Human papillomavirus type 31 E7 protein; Protein E7; HPV31 E7 protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: HPV31.
●
Immunogen: KLH conjugated synthetic peptide derived from HPV31 E7 prote.
●
Predicted Molecular Weight: 11kDa.Anti-HPV31 E7抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-HPV31 E7抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-HPV31 E7抗體
Optimal working dilutions must be determined by the end user.
kl940Hu01 趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體 Polyclonal Antibody to Chemokine C-X-C-Motif Receptor 4 (CXCR4)
kl940Mu01 趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體 Polyclonal Antibody to Chemokine C-X-C-Motif Receptor 4 (CXCR4)
kl940Po01 趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體 Polyclonal Antibody to Chemokine C-X-C-Motif Receptor 4 (CXCR4)
kl944Hu01 巖藻糖基轉(zhuǎn)移酶3(FUT3)多克隆抗體 Polyclonal Antibody to Fucosyltransferase 3 (FUT3)
kl945Hu01 趨化素(CHEM)多克隆抗體 Polyclonal Antibody to Chemerin (CHEM)
kl945Ra01 趨化素(CHEM)多克隆抗體 Polyclonal Antibody to Chemerin (CHEM)
kl948Hu01 胸腺嘧啶核苷磷酸化酶(TP)多克隆抗體 Polyclonal Antibody to Thymidine Phosphorylase (TP)
kl948Mu01 胸腺嘧啶核苷磷酸化酶(TP)多克隆抗體 Polyclonal Antibody to Thymidine Phosphorylase (TP)
kl950Hu01 血管性血友病因子裂解蛋白酶(vWFCP)多克隆抗體 Polyclonal Antibody to Von Willebrand Factor Cleaving Protease (vWFCP)
kl959Hu01 L1-細胞粘附分子(L1CAM)多克隆抗體 Polyclonal Antibody to L1-Cell Adhesion Molecule (L1CAM)
kl959Mu01 L1-細胞粘附分子(L1CAM)多克隆抗體 Polyclonal Antibody to L1-Cell Adhesion Molecule (L1CAM)
kl960Hu01 ATP結(jié)合盒轉(zhuǎn)運蛋白G2(ABCG2)多克隆抗體 Polyclonal Antibody to ATP Binding Cassette Transporter G2 (ABCG2)
kl960Mu01 ATP結(jié)合盒轉(zhuǎn)運蛋白G2(ABCG2)多克隆抗體 Polyclonal Antibody to ATP Binding Cassette Transporter G2 (ABCG2)
kl965Hu01 α2-巨球蛋白樣蛋白1(α2ML1)多克隆抗體 Polyclonal Antibody to Alpha-2-Macroglobulin Like Protein 1 (a2ML1)
kl966Hu01 唾液酸結(jié)合Ig樣凝集素1(SIGLEC1)多克隆抗體 Polyclonal Antibody to Sialic Acid Binding Ig Like Lectin 1 (SIGLEC1)
kl971Hu01 磷脂酰肌醇蛋白聚糖3(GPC3)多克隆抗體 Polyclonal Antibody to Glypican 3 (GPC3)
kl973Hu01 血管緊張素Ⅱ受體2(AGTR2)多克隆抗體 Polyclonal Antibody to Angiotensin II Receptor 2 (AGTR2)
